Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)

China flag China · Delayed Price · Currency is CNY
24.27
+0.86 (3.67%)
At close: Mar 6, 2026
Market Cap2.63B +35.6%
Revenue (ttm)196.21M +0.7%
Net Income51.71M +16.8%
EPS0.48 +17.1%
Shares Out108.22M
PE Ratio50.56
Forward PEn/a
Dividend0.32 (1.32%)
Ex-Dividend DateSep 26, 2025
Volume1,098,505
Average Volume1,639,809
Open23.41
Previous Close23.41
Day's Range23.17 - 24.34
52-Week Range14.46 - 28.93
Beta0.54
RSI45.03
Earnings DateApr 25, 2026

About SHA:688163

Shanghai Serum Bio-Technology Co., Ltd. engages in the research, development, production, operation, and sales of antitoxin and antiserum products in China. It offers equine anti-tetanus immunoglobulin, anti-venin, and anti-rabies serum products. The company was founded in 1999 and is based in Shanghai, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1999
Employees 324
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688163
Full Company Profile

Financial Performance

In 2025, SHA:688163's revenue was 196.21 million, an increase of 0.66% compared to the previous year's 194.92 million. Earnings were 51.71 million, an increase of 16.76%.

Financial Statements